Vimarsana
Biggest News Aggregation in the World

Page 20 - Project Bioshield News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Project Bioshield. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Project Bioshield Today - Breaking & Trending Today

HHS buys $290 million worth of radiation sickness drugs in preparation for nuclear emergencies - Vimarsana News

HHS buys $290 million worth of radiation sickness drugs in preparation for nuclear emergencies

The Department of Health and Human Services (HHS) is buying $290 million worth of drugs meant for treating radiation sickness in preparation for a nuclear emergency. This purchase was announced [...]

US Spends $290M In Anti-Radiation Pills Amid 'Armageddon' Nuclear Risk | Newstalk 1400, 104.5, and 105.9 - Vimarsana News

US Spends $290M In Anti-Radiation Pills Amid 'Armageddon' Nuclear Risk | Newstalk 1400, 104.5, and 105.9

The risk of nuclear 'Armageddon' is reported to be the highest since the 1962 Cuban Missile Crisis.

Source: iheart.com
US Spends $290M In Anti-Radiation Pills Amid 'Armageddon' Nuclear Risk | News Radio 1410 AM & 100.9 FM - Vimarsana News

US Spends $290M In Anti-Radiation Pills Amid 'Armageddon' Nuclear Risk | News Radio 1410 AM & 100.9 FM

The risk of nuclear 'Armageddon' is reported to be the highest since the 1962 Cuban Missile Crisis.

Source: iheart.com
US Spends $290M In Anti-Radiation Pills Amid 'Armageddon' Nuclear Risk - Vimarsana News

US Spends $290M In Anti-Radiation Pills Amid 'Armageddon' Nuclear Risk

The risk of nuclear 'Armageddon' is reported to be the highest since the 1962 Cuban Missile Crisis.

Source: iheart.com
US Spends $290M In Anti-Radiation Pills Amid 'Armageddon' Nuclear Risk | 96.3 - Vimarsana News

US Spends $290M In Anti-Radiation Pills Amid 'Armageddon' Nuclear Risk | 96.3

The risk of nuclear 'Armageddon' is reported to be the highest since the 1962 Cuban Missile Crisis.

Source: iheart.com